Lataa...
Immune Checkpoint PD-1/PD-L1: Is There Life Beyond Antibodies?
[Image: see text] The PD-1/PD-L1 interaction has emerged as a significant target in cancer immunotherapy. Current medications include monoclonal antibodies, which have shown impressive clinical results in the treatment of several types of tumors. The cocrystal structure of human PD-1 and PD-L1 is ex...
Tallennettuna:
| Julkaisussa: | Angew Chem Int Ed Engl |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280658/ https://ncbi.nlm.nih.gov/pubmed/29178534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201710407 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|